CRNX logo

CRNX Cash From Operations

CRNX Annual CFO

-$166.31 M
-$51.10 M-44.36%

31 December 2023

CRNX Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRNX Quarterly CFO

-$62.82 M
-$17.21 M-37.72%

30 September 2024

CRNX Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRNX TTM CFO

-$199.81 M
-$21.48 M-12.05%

30 September 2024

CRNX TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRNX Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.4%-52.0%-22.6%
3 y3 years-168.1%-52.0%-22.6%
5 y5 years-754.6%-52.0%-22.6%

CRNX Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-87.7%at low-363.9%at low-143.5%at low
5 y5-year-258.6%at low-413.7%at low-330.8%at low
alltimeall time-2941.5%at low-2756.9%at low-8490.3%at low

Crinetics Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$62.82 M(+37.7%)
-$199.81 M(+12.0%)
June 2024
-
-$45.62 M(-13.7%)
-$178.33 M(-0.1%)
Mar 2024
-
-$52.86 M(+37.2%)
-$178.44 M(+7.3%)
Dec 2023
-$166.31 M(+44.4%)
-$38.52 M(-6.8%)
-$166.31 M(+2.0%)
Sept 2023
-
-$41.34 M(-9.6%)
-$163.00 M(+1.8%)
June 2023
-
-$45.73 M(+12.3%)
-$160.14 M(+12.5%)
Mar 2023
-
-$40.72 M(+15.7%)
-$142.38 M(+23.6%)
Dec 2022
-$115.20 M(+30.0%)
-$35.21 M(-8.5%)
-$115.20 M(+12.0%)
Sept 2022
-
-$38.48 M(+37.5%)
-$102.90 M(+14.2%)
June 2022
-
-$27.98 M(+106.6%)
-$90.09 M(+9.8%)
Mar 2022
-
-$13.54 M(-40.9%)
-$82.06 M(-7.4%)
Dec 2021
-$88.59 M(+42.8%)
-$22.90 M(-10.8%)
-$88.59 M(+8.5%)
Sept 2021
-
-$25.67 M(+28.7%)
-$81.63 M(+10.4%)
June 2021
-
-$19.95 M(-0.6%)
-$73.96 M(+5.9%)
Mar 2021
-
-$20.07 M(+25.9%)
-$69.86 M(+12.6%)
Dec 2020
-$62.03 M
-$15.94 M(-11.5%)
-$62.03 M(+4.2%)
DateAnnualQuarterlyTTM
Sept 2020
-
-$18.00 M(+13.6%)
-$59.54 M(+8.0%)
June 2020
-
-$15.86 M(+29.6%)
-$55.14 M(+6.3%)
Mar 2020
-
-$12.23 M(-9.1%)
-$51.85 M(+11.8%)
Dec 2019
-$46.38 M(+138.4%)
-$13.45 M(-1.2%)
-$46.38 M(+19.1%)
Sept 2019
-
-$13.61 M(+8.3%)
-$38.94 M(+25.5%)
June 2019
-
-$12.57 M(+85.9%)
-$31.03 M(+36.0%)
Mar 2019
-
-$6.76 M(+12.5%)
-$22.81 M(+17.2%)
Dec 2018
-$19.46 M(+105.3%)
-$6.01 M(+5.6%)
-$19.46 M(+21.9%)
Sept 2018
-
-$5.69 M(+30.9%)
-$15.96 M(+25.6%)
June 2018
-
-$4.35 M(+27.7%)
-$12.71 M(+20.4%)
Mar 2018
-
-$3.41 M(+35.7%)
-$10.56 M(+11.4%)
Dec 2017
-$9.48 M(+73.4%)
-$2.51 M(+2.8%)
-$9.48 M(+36.0%)
Sept 2017
-
-$2.44 M(+11.1%)
-$6.97 M(+54.0%)
June 2017
-
-$2.20 M(-5.5%)
-$4.53 M(+94.5%)
Mar 2017
-
-$2.33 M
-$2.33 M
Dec 2016
-$5.47 M
-
-

FAQ

  • What is Crinetics Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals annual CFO year-on-year change?
  • What is Crinetics Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals quarterly CFO year-on-year change?
  • What is Crinetics Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Crinetics Pharmaceuticals?
  • What is Crinetics Pharmaceuticals TTM CFO year-on-year change?

What is Crinetics Pharmaceuticals annual cash flow from operations?

The current annual CFO of CRNX is -$166.31 M

What is the all time high annual CFO for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high annual cash flow from operations is -$5.47 M

What is Crinetics Pharmaceuticals annual CFO year-on-year change?

Over the past year, CRNX annual cash flow from operations has changed by -$51.10 M (-44.36%)

What is Crinetics Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of CRNX is -$62.82 M

What is the all time high quarterly CFO for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high quarterly cash flow from operations is -$2.20 M

What is Crinetics Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, CRNX quarterly cash flow from operations has changed by -$21.48 M (-51.97%)

What is Crinetics Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of CRNX is -$199.81 M

What is the all time high TTM CFO for Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals all-time high TTM cash flow from operations is -$2.33 M

What is Crinetics Pharmaceuticals TTM CFO year-on-year change?

Over the past year, CRNX TTM cash flow from operations has changed by -$36.81 M (-22.58%)